City

Boston (1)

Chicago (1)

Nashville (1)

New Lenox (1)

Orland Park (1)

Philadelphia (1)

San Francisco (1)

Condition

Breast Cancer (1)

Circulating Tumor DNA (1)

Residual Cancer (1)

Triple Negative Breast Cancer (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Dana-Farber Cancer Institute (1)

Collaborator

Genentech, Inc. (1)

Stand Up To Cancer (1)

Intervention

atezolizumab (1)

sacituzumab govitecan (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

residual cancer

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Breast Cancer, Triple Negative Breast Cancer, Residual Cancer Trial in United States (Atezolizumab, Sacituzumab govitecan)

Recruiting

Breast Cancer
+3 more

Atezolizumab
Sacituzumab govitecan

San Francisco, California
+8 more

May 25, 2022